Advanced Pharmacovigilance Course - London, U.K. - 25th-27th September 2017 - Research and Markets

DUBLIN, July 8, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Advanced Pharmacovigilance (London, U.K. - 25th-27th September 2017)" conference to their offering.

This course is designed for those with at least two years worth of knowledge in drug safety and will provide a comprehensive, yet practical assessment of the main regulations required to produce a compliant reporting company pharmacovigilance Inspection.

Key Topics To Be Covered

- Training for Drug Safety Reporting Duties, Audits and Expectations Risk Based Inspections

- The DDPS retirement and the New PV Master file in the EU

- Compliance and Drug Safety

- Product Safety Reviews Purpose and Function (incorporating the new EU Signal Analysis Requirements)

- Developing Company Core System Information CIOMS III

- Safety Reporting in Licensing Agreements

- PSURs Timing, Content and the DSUR and the New ICH E2C (2nd Revision requirements)

- Implications for Safety Reporting in Global Clinical Trials

- Risk/Benefit Determinations - Risk Management Plans

Why you should attend

- Expand your global safety knowledge

- Enhance your team's capabilities and compliance in both the regulations and your company's expectations

- Help ensure you build and maintain a quality Pharmacovigilance department ready for any Pharmacovigilance inspection

- Participate in group workshop sessions and discuss how to apply the legislation to ensure compliance, especially to satisfy regulatory inspection

For more information visit http://www.researchandmarkets.com/research/pq8bgp/advanced

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]